The role of MDSCs in hepatocellular carcinoma - In vivo veritas?

Journal of Hepatology

Volumn 59, Issue 5, 2013, Pages 921-923

  Schrader, Jörg ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CHEMOKINE; CYTOKINE; DOCETAXEL; FLUOROURACIL; GEMCITABINE; INTERLEUKIN 8;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BLOOD; BONE MARROW; BONE MARROW CELL; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DRUG EFFICACY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE; MACROPHAGE; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REGULATORY T LYMPHOCYTE; REVIEW; SPLEEN; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

HCC; HEPATOCELLULAR CARCINOMA; MDSC; MYELOID DERIVED SUPPRESSOR CELL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; LIVER NEOPLASMS; MYELOID CELLS;

EID: 84885951988     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.08.003     Document Type: Editorial

References (15)

1. T.J. Waldron, J.G. Quatromoni, T.A. Karakasheva, S. Singhal, and A.K. Rustgi Myeloid derived suppressor cells: targets for therapy Oncoimmunology 2 2013 e24117
2. B. Hoechst, L.A. Ormandy, M. Ballmaier, F. Lehner, C. Krüger, and M.P. Manns A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells Gastroenterology 135 2008 234 243
3. S. Kalathil, A.A. Lugade, A. Miller, R. Iyer, and Y. Thanavala Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality Cancer Res 73 2013 2435 2444
4. F. Arihara, E. Mizukoshi, M. Kitahara, Y. Takata, K. Arai, and T. Yamashita Increase in CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis Cancer Immunol Immunother 62 2013 1421 1430
5. T. Kapanadze, J. Gamrekelashvili, C. Ma, C. Chan, F. Zhao, and S. Hewitt Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma J Hepatol 56 2013 1007 1013
6. D.I. Gabrilovich, and S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 2009 162 174
7. T. Chan, R.H. Wiltrout, and J.M. Weiss Immunotherapeutic modulation of the suppressive liver and tumor microenvironments Int Immunopharmacol 11 2011 879 889
8. C. Ma, T. Kapanadze, J. Gamrekelashvili, M.P. Manns, F. Korangy, and T.F. Greten Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice J Leukoc Biol 92 2012 1199 1206
9. K. Schmidt, S. Zilio, J.C. Schmollinger, V. Bronte, T. Blankenstein, and G. Willimsky Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer Blood 121 2013 1740 1748
10. L. Yang, L.M. DeBusk, K. Fukuda, B. Fingleton, B. Green-Jarvis, and Y. Shyr Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis Cancer Cell 6 2004 409 421
11. Y.G. Najjar, and J.H. Finke Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer Front Oncol 3 2013 49
12. M.K. Srivastava, L. Zhu, M. Harris-White, U.K. Kar, M. Huang, and M.F. Johnson Myeloid suppressor cell depletion augments antitumor activity in lung cancer PLoS One 7 2012 e40677
13. P.Y. Pan, G.X. Wang, B. Yin, J. Ozao, T. Ku, and C.M. Divino Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function Blood 111 2008 219 228
14. H.H. Yan, M. Pickup, Y. Pang, A.E. Gorska, Z. Li, and A. Chytil Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung Cancer Res. 70 2010 6139 6149
15. P. Shen, A. Wang, M. He, Q. Wang, and S. Zheng Increased circulating Lin-/low CD33+ HLA-DR- myeloid-derived suppressor cells in hepatocellular carcinoma patients Hepatol Res 2013 10.1111/hepr.12167